Direct Transcriptional Targets of Sex Steroid Hormones in Bone

Overview

Journal J Cell Biochem

Specialties Biochemistry
Cell Biology

Date 2011 Jan 27

PMID 21268060

Citations 34

Authors

Susan A Krum

Affiliations

Soon will be listed here.

Abstract

The sex steroid hormones, androgens and estrogens, via their respective nuclear receptors, regulate bone mineral density in humans and mice. Very little is known about the direct targets of the androgen and estrogen receptors in bone cells. First, models of hormone and receptor deficiency in mouse and human bone are discussed. This review then focuses on the direct targets of the receptors in osteoblasts and osteoclasts. A direct target of a NR is defined here as a gene that is regulated by NR binding to the DNA (either through DNA binding or association with a DNA binding protein) at an enhancer or promoter of that gene. The experimental evidence that illustrates androgen and estrogen gene regulation in osteoblasts and osteoclasts will be summarized and compared with the phenotype of the hormones in vivo.

Citing Articles

Sex steroid hormones: an overlooked yet fundamental factor in oral homeostasis in humans.

Cornejo Ulloa P, Krom B, Schoonmade L, van der Veen M Front Endocrinol (Lausanne). 2024; 15:1400640.

PMID: 39109076 PMC: 11300310. DOI: 10.3389/fendo.2024.1400640.

Effect of different types of Tai Chi exercise programs on the rate of change in bone mineral density in middle-aged adults at risk of osteoporosis: a randomized controlled trial.

Kong J, Tian C, Zhu L J Orthop Surg Res. 2023; 18(1):949.

PMID: 38072989 PMC: 10712169. DOI: 10.1186/s13018-023-04324-0.

Regulation and Function of FOXC1 in Osteoblasts.

Suthon S, Lin J, Perkins R, Miranda-Carboni G, Krum S J Dev Biol. 2023; 11(3).

PMID: 37754840 PMC: 10531946. DOI: 10.3390/jdb11030038.

Current Status of the Diagnosis and Management of Osteoporosis.

Aibar-Almazan A, Voltes-Martinez A, Castellote-Caballero Y, Afanador-Restrepo D, Carcelen-Fraile M, Lopez-Ruiz E Int J Mol Sci. 2022; 23(16).

PMID: 36012730 PMC: 9408932. DOI: 10.3390/ijms23169465.

The ERα/KDM6B regulatory axis modulates osteogenic differentiation in human mesenchymal stem cells.

Liu Z, Lee H, Suh J, Deng P, Lee C, Bezouglaia O Bone Res. 2022; 10(1):3.

PMID: 34992221 PMC: 8738748. DOI: 10.1038/s41413-021-00171-z.

References

Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J . Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab. 1990; 71(5):1322-9. DOI: 10.1210/jcem-71-5-1322. View

Zhou S, Turgeman G, Harris S, Leitman D, Komm B, Bodine P . Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol. 2003; 17(1):56-66. DOI: 10.1210/me.2002-0210. View

Zhang J, Pugh T, Stebler B, Ershler W, Keller E . Orchiectomy increases bone marrow interleukin-6 levels in mice. Calcif Tissue Int. 1998; 62(3):219-26. DOI: 10.1007/s002239900421. View

Hofbauer L, Ten R, Khosla S . The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Miner Res. 1999; 14(8):1330-7. DOI: 10.1359/jbmr.1999.14.8.1330. View

Krum S, Miranda-Carboni G, Lupien M, Eeckhoute J, Carroll J, Brown M . Unique ERalpha cistromes control cell type-specific gene regulation. Mol Endocrinol. 2008; 22(11):2393-406. PMC: 2582540. DOI: 10.1210/me.2008-0100. View

Krum S, Brown M . Unraveling estrogen action in osteoporosis. Cell Cycle. 2008; 7(10):1348-52. DOI: 10.4161/cc.7.10.5892. View

Michael H, Harkonen P, Vaananen H, Hentunen T . Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res. 2005; 20(12):2224-32. DOI: 10.1359/JBMR.050803. View

Samudio I, Safe S . Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem. 2001; 276(33):30853-61. DOI: 10.1074/jbc.M103339200. View

Bord S, Ireland D, Beavan S, Compston J . The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone. 2003; 32(2):136-41. DOI: 10.1016/s8756-3282(02)00953-5. View

10.

Villavicencio-Lorini P, Kuss P, Friedrich J, Haupt J, Farooq M, Turkmen S . Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J Clin Invest. 2010; 120(6):1994-2004. PMC: 2877951. DOI: 10.1172/JCI41554. View

11.

Braidman I, Hainey L, Batra G, Selby P, Saunders P, Hoyland J . Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res. 2001; 16(2):214-20. DOI: 10.1359/jbmr.2001.16.2.214. View

12.

Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamaru Y, Shiokawa M . Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun. 1996; 223(3):637-42. DOI: 10.1006/bbrc.1996.0947. View

13.

Hofbauer L, Hicok K, Chen D, Khosla S . Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. Eur J Endocrinol. 2002; 147(2):269-73. DOI: 10.1530/eje.0.1470269. View

14.

Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M . Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997; 186(4):489-95. PMC: 2199029. DOI: 10.1084/jem.186.4.489. View

15.

Plant A, Tobias J . Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration. J Bone Miner Res. 2002; 17(5):782-90. DOI: 10.1359/jbmr.2002.17.5.782. View

16.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

17.

Robinson J, Harris S, Riggs B, Spelsberg T . Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology. 1997; 138(7):2919-27. DOI: 10.1210/endo.138.7.5277. View

18.

Yang N, Bryant H, Hardikar S, Sato M, Galvin R, Glasebrook A . Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology. 1996; 137(5):2075-84. DOI: 10.1210/endo.137.5.8612550. View

19.

Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein R . The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010; 24(2):323-34. PMC: 2817608. DOI: 10.1210/me.2009-0354. View

20.

Chen X, Garner S, Quarles L, Anderson J . Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. J Nutr Biochem. 2003; 14(6):342-9. DOI: 10.1016/s0955-2863(03)00056-1. View